Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)
Key claim: MR Fingerprinting and phosphorus-31 MR spectroscopy are proposed to characterize skeletal muscle in heart-failure patients with sarcopenia via quantitative T1, T2, and post-exercise phosphocreatine recovery profiles.
Abstract
The goal of the proposed research is to investigate Magnetic Resonance (MR) Fingerprinting and P-MRS (Phosphorus-31 MR Spectroscopy) imaging for characterization of skeletal muscle in heart failure patients with sarcopenia. Heart failure patients with and without sarcopenia will be scanned using MR Fingerprinting and an existing Post-exercise phosphocreatine (PCr) recovery MR imaging protocol to obtain characteristic profiles of quantitative T1, T2, and PCr recovery rate.
Why this matters
MR Fingerprinting and phosphorus-31 MR spectroscopy are proposed to characterize skeletal muscle in heart-failure patients with sarcopenia via quantitative T1, T2, and post-exercise phosphocreatine recovery profiles.